Market Overview

iBio Skyrockets; Bob Simon's Last 60 Minutes Story Is On ZMapp

Related IBIO
25 Stocks Moving In Friday's Pre-Market Session Following Brexit
Scientific Insights Into IBIO-CFB03 Presented at American College of Rheumatology Annual Meeting

Ibio Inc (NYSE: IBIO) added more than 66 percent this Friday after 60 Minutes announced that Bob Simon’s last story would be on ZMapp, an Ebola drug made from tobacco.

IBio helps Mapp Biopharmaceutical, which developed ZMapp, with its plant-based antibody manufacturing technology. Bob Simon reportedly finished producing the episode the day he died in a car accident.

In the trailer for Simon’s report, the anchor can be seen discussing ZMapp with the CEO of Kentucky Bioprocessing – a tobacco grower and new subsidiary of Reynolds American, Inc. (NYSE: RAI).

The report will air this Sunday, February 15 at 7 p.m. ET.

Posted-In: 60 minutes Bob SimonLong Ideas Intraday Update Movers Trading Ideas


Related Articles (RAI + IBIO)

View Comments and Join the Discussion!